Greenwoods Asset Management Hong Kong Ltd. Zai Lab LTD Transaction History

Greenwoods Asset Management Hong Kong Ltd.

$3.79 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $336,428 - $584,521	15,100 New	15,100 $463,000
Q2 2021 Aug 13, 2021	SELL	$125.11 - $180.0 $4.63 Million - $6.66 Million	-37,015 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $4.67 Million - $7.1 Million	37,015 New	37,015 $4.94 Million

Others Institutions Holding ZLAB

# of Institutions

116

Shares Held

40.8M

Call Options Held

63.1K

Put Options Held

420K

Wellington Management Group LLP Boston, MA

7.12M
Shares

$220 Million
0.02% of portfolio
Janus Henderson Group PLC London, X0

6.53M
Shares

$201 Million
0.06% of portfolio
Capital World Investors Los Angeles, CA

5.31M
Shares

$164 Million
0.02% of portfolio
Woodline Partners LP San Francisco, CA

2.33M
Shares

$72 Million
0.41% of portfolio
Viking Global Investors LP

2.04M
Shares

$62.9 Million
0.14% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwoods Asset Management Hong Kong Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Greenwoods Asset Management Hong Kong Ltd. with notifications on news.

Account